Disclosure Of Entity's Operating Segments [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183075

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of entity's operating segments [text block]
Description des secteurs
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
66,997,000 EUR
22,668,000 EUR
Tax expense (income)
48 139 EUR
6 895 EUR
Profit (loss) before tax
11 480 EUR
123 769 EUR
Profit (loss)
59 620 EUR
59 620 EUR
116 875 EUR
116 875 EUR
Assets
442 414 EUR
421 918 EUR
Cash flows from (used in) operating activities
56 819 EUR
76 788 EUR
Cash flows from (used in) investing activities
25 490 EUR
54 682 EUR
Cash flows from (used in) financing activities
77 869 EUR
25 646 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.